Heartlands Hospital is an acute general hospital in Bordesley Green, Birmingham, England. It is managed by University Hospitals Birmingham NHS Foundation Trust.

During the past decade, Birmingham Heartlands Hospital conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 42 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 30 clinical trials were completed. i.e. 214.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Birmingham Heartlands Hospital" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "University College, London" with 11 trials sponsored, "University of Birmingham" with 6 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 6 trials sponsored and "Gilead Sciences" with 6 trials sponsored. Other sponsors include 142 different institutions and companies that sponsored additional 104 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Birmingham Heartlands Hospital" #1 collaborator was "Cancer Research UK" with 7 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 7 trials as a collaborator, "Medical Research Council" with 5 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 3 trials as a collaborator and "Celgene" with 3 trials as a collaborator. Other collaborators include 193 different institutions and companies that were collaborators in the rest 168 trials.

According to Clinical.Site data, the most researched conditions in "Birmingham Heartlands Hospital" are "Cystic Fibrosis" (12 trials), "Lymphoma" (12 trials), "Asthma" (9 trials), "Multiple Myeloma" (9 trials) and "Leukemia" (6 trials). Many other conditions were trialed in "Birmingham Heartlands Hospital" in a lesser frequency.

Most popular intervention types in "Birmingham Heartlands Hospital" are "Drug" (133 trials), "Other" (24 trials), "Procedure" (20 trials), "Biological" (19 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "cyclophosphamide" (8 trials), "Cyclophosphamide" (6 trials), "fludarabine phosphate" (6 trials) and "Atezolizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Birmingham Heartlands Hospital" are 175 trials for "All" genders, 7 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Birmingham Heartlands Hospital". undefined are not yet recruiting, 16 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 102 completed trials in Birmingham Heartlands Hospital, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Birmingham Heartlands Hospital, 13 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 19 trials that are defined as “Not Applicable".